文献速递肝胆胰外科围术期管理与 ERAS

机器人辅助与开放根治性肾切除加静脉瘤栓取出术的围手术期与肿瘤学结局:逆概率加权分析

Robot‑assisted versus open radical nephrectomy and venous tumor thrombectomy: perioperative and oncologic outcomes-an inverse probability of treatment weighting analysis.
PubMed 文献 · Surg Endosc · 2026-08-19

该回顾性队列研究纳入418例肾细胞癌合并静脉瘤栓患者(机器人组239例,开放组179例),采用逆概率加权平衡19项基线协变量后比较围手术期与肿瘤学结局。结果显示机器人组手术时间更短、出血量更少、输血量更低、住院时间更短,输血和术后并发症风险更低,无进展生存无显著差异。

要点

  • 机器人组围手术期结局优于开放组,包括手术时间、出血量、输血量、住院时间和并发症。
  • 两组无进展生存期无显著差异(log-rank P > 0.05)。
  • 需前瞻性或随机研究进一步验证机器人入路的肿瘤学等效性或优越性。

核心结论

  • 对于肾细胞癌合并静脉瘤栓患者,机器人辅助根治性肾切除加静脉瘤栓取出术与改善的围手术期结局相关。

研究设计与样本

  • 回顾性队列研究,纳入2014至2025年间在高容量中心治疗的418例患者(机器人组239例,开放组179例)。
  • 采用协变量平衡倾向评分方法进行逆概率加权,平衡19项基线协变量。
  • 围手术期结局采用加权回归分析,无进展生存和总生存采用加权Cox回归分析。
  • 敏感性分析包括倾向评分匹配和重叠时间期分析(2020-2025)。

主要发现

  • 逆概率加权后所有协变量均衡良好。
  • 机器人组手术时间显著更短(β = -91.63),估计出血量更少(β = -885.05),输血量更低(β = -561.32),住院时间更短(β = -2.79)。
  • 机器人组输血风险降低(OR = 0.26),任何术后并发症风险降低(OR = 0.44),所有P < 0.001。
  • 无进展生存期两组无显著差异(log-rank P > 0.05)。
  • 两项敏感性分析均证实机器人组围手术期结局更优。

临床怎么用

  • 在适合的患者中,机器人辅助入路可能减少手术创伤、输血需求和并发症,缩短住院时间。
  • 肿瘤学结局需长期随访评估,目前无进展生存无显著差异。

局限性

  • 回顾性研究设计,存在选择偏倚可能。
  • 单中心数据,外推性受限。
  • 需前瞻性或随机研究进一步验证肿瘤学等效性或优越性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Open radical nephrectomy and venous thrombectomy (ORN‑VT) is standard for renal cell carcinoma with tumor thrombus (RCC-TT), but robot‑assisted radical nephrectomy and venous thrombectomy (RARN‑VT) may improve outcomes. We used inverse probability of treatment weighting (IPTW) to compare perioperative and oncologic results. METHODS: This retrospective cohort study included 418 patients (239 RARN‑VT, 179 ORN‑VT) treated at a high‑volume center between 2014 and 2025. IPTW balanced 19 baseline covariates using the covariate balancing propensity score method. Weighted regression was used for perioperative outcomes, and weighted Cox regression for progression‑free survival (PFS) and overall survival (OS). Propensity score matching (PSM) and an overlapping time‑period analysis (2020-2025) were performed as sensitivity analyses. RESULTS: After IPTW, all covariates were well balanced. RARN‑VT was associated with significantly shorter operation time (β = - 91.63), less estimated blood loss (β = - 885.05), lower transfusion volume (β = - 561.32), shorter length of stay (β = - 2.79), and reduced odds of blood transfusion (OR = 0.26) and any postoperative complication (OR = 0.44) (all P < 0.001). PFS showed no significant difference between approaches (log‑rank P > 0.05). Both sensitivity analyses confirmed the association between RARN‑VT and better perioperative outcomes. CONCLUSIONS: For RCC and TT patients, RARN‑VT was associated with improved perioperative outcomes. Prospective or randomized studies are warranted to further explore the oncological equivalence or superiority of the robotic approach.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Yu L, Duan P, Tian Y, et al. Robot‑assisted versus open radical nephrectomy and venous tumor thrombectomy: perioperative and oncologic outcomes-an inverse probability of treatment weighting analysis. Surg Endosc. 2026. PMID: 42618819. doi:10.1007/s00464-026-13276-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。